Article
Pancreatic cancer survival analysis defines a signature that predicts outcome
9 Aug 2018
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in the US. Despite multiple large-scale genetic sequencing studies, identification of predictors of patient survival remains challenging. We performed a comprehensive assessment and integrative analysis of large-scale gene expression datasets, across multiple platforms, to enable discovery of a prognostic gene signature for patient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
